{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T19:36:44Z","timestamp":1767987404836,"version":"3.49.0"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2016,5,31]],"date-time":"2016-05-31T00:00:00Z","timestamp":1464652800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002753","name":"Universidad Nacional de Colombia","doi-asserted-by":"publisher","award":["HERMES-18994"],"award-info":[{"award-number":["HERMES-18994"]}],"id":[{"id":"10.13039\/501100002753","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007637","name":"Colciencias","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007637","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0004739","type":"journal-article","created":{"date-parts":[[2016,5,31]],"date-time":"2016-05-31T13:33:33Z","timestamp":1464701613000},"page":"e0004739","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":23,"title":["Clinical and Parasitological Features of Patients with American Cutaneous Leishmaniasis that Did Not Respond to Treatment with Meglumine Antimoniate"],"prefix":"10.1371","volume":"10","author":[{"given":"Jairo E.","family":"Perez-Franco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00f3nica L.","family":"Cruz-Barrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta L.","family":"Robayo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myriam C.","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos D.","family":"Daza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Bedoya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria L.","family":"Mari\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos H.","family":"Saavedra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5590-6470","authenticated-orcid":false,"given":"Maria C.","family":"Echeverry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2016,5,31]]},"reference":[{"issue":"1","key":"ref1","first-page":"1","article-title":"Clinical spectrum of Leishmaniasis","volume":"22","author":"R Pearson","year":"1996"},{"issue":"1","key":"ref2","first-page":"259","article-title":"Quality of diagnosis of canine visceral leishmaniasis in epidemiological surveys: an epidemic in Belo Horizonte, Minas Gerais, Brazil, 1993\u20131997","volume":"20","author":"W Alves","year":"2004"},{"issue":"8","key":"ref3","first-page":"525","article-title":"Recent advances in leishmaniasis treatment","volume":"15","author":"T Tiuman","year":"2011"},{"key":"ref4","unstructured":"World Health Organization (2010) Control of the leishmaniasis. Report of a meeting of the WHO Expert Committee on the Control of Leishmaniases, Geneva, 22\u201326 March 2010. WHO technical report series 949. Geneva, Switzerland: World Health Organization."},{"issue":"3","key":"ref5","first-page":"579","article-title":"New World and Old World Leishmania Infections: A Practical Review","volume":"33","author":"I Kevric","year":"2015"},{"issue":"5","key":"ref6","first-page":"e2871","article-title":"Miltefosine and antimonial drug susceptibility of Leishmania Viannia species and populations in regions of high transmission in Colombia","volume":"8","author":"OL Fern\u00e1ndez","year":"2014"},{"key":"ref7","first-page":"145","article-title":"Geographic distribution of Leishmania species isolated from patients at the National Institute of Dermatology Federico Lleras Acosta E.S.E., 1995\u20132005","volume":"Suppl 1","author":"CE Ovalle","year":"2006"},{"issue":"3","key":"ref8","first-page":"206","article-title":"Distribution and etiology ofleishmaniasis in Colombia","volume":"42","author":"A Corredor","year":"1990"},{"issue":"5","key":"ref9","first-page":"456","article-title":"Comparison of cutaneous leishmaniasis due to <italic>Leishmania<\/italic> (Viannia) <italic>braziliensis<\/italic> and <italic>L<\/italic>. (V.) <italic>guyanensis<\/italic> in Brazil: therapeutic response to meglumine antimoniate","volume":"65","author":"G Romero","year":"2001"},{"issue":"3","key":"ref10","first-page":"528","article-title":"Placebo-controlled clinical trial of sodium stibogluconate (Pentostam) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala","volume":"165","author":"TR Navin","year":"1992"},{"issue":"6","key":"ref11","first-page":"e1656","article-title":"Prediction score for antimony treatment failure in patients with ulcerative leishmaniasis lesions","volume":"6","author":"C Valencia","year":"2012"},{"issue":"12","key":"ref12","first-page":"1846","article-title":"Influence of Leishmania (Viannia) species on the response to antimonial treatment in patients with American tegumentary leishmaniasis","volume":"195","author":"J Arevalo","year":"2007"},{"issue":"2","key":"ref13","first-page":"223","article-title":"Clinical and parasite species risk factors for pentavalent antimonial treatment failure in cutaneous leishmaniasis in Peru","volume":"46","author":"A Llanos-Cuentas","year":"2008"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(98)10178-2","article-title":"Leishmaniasis","volume":"354","author":"B Herwaldt","year":"1999","journal-title":"Lancet"},{"issue":"6","key":"ref15","first-page":"485","article-title":"Leishmaniasis: Current status of available drugs and new potential drug targets","volume":"5","author":"N Singh","year":"2012"},{"issue":"2","key":"ref16","first-page":"109","article-title":"Treatment of New World cutaneous leishmaniasis\u2014a systematic review with a meta-analysis","volume":"47","author":"FF Tuon","year":"2008"},{"issue":"3","key":"ref17","first-page":"193","article-title":"Pharmacokinetics of experimental pentavalent antimony after intramuscular administration in adult volunteers","volume":"67","author":"L V\u00e1squez","year":"2006"},{"issue":"1","key":"ref18","first-page":"111","article-title":"Drug Resistance in Leishmaniasis","volume":"19","author":"S Croft","year":"2006"},{"issue":"8","key":"ref19","first-page":"937","article-title":"Treatment failure in leishmaniasis: drug-resistance or another (epi-) phenotype?","volume":"12","author":"M Vanaerschot","year":"2014"},{"issue":"10","key":"ref20","first-page":"1375","article-title":"Resistance to antimony and treatment failure in human <italic>Leishmania<\/italic> (Viannia) infection","volume":"193","author":"R Rojas","year":"2006"},{"key":"ref21","first-page":"209","article-title":"Resistance of Leishmania (Viannia) braziliensis to nitric oxide: correlation with antimony therapy and TNF-alpha production","volume":"10","author":"AS Souza","year":"2010"},{"issue":"3","key":"ref22","first-page":"e2130","article-title":"Methodology of clinical trials aimed at assessing interventions for cutaneous leishmaniasis","volume":"7","author":"P Olliaro","year":"2013"},{"issue":"4","key":"ref23","first-page":"1339","article-title":"Improving Leishmania species identification in different types of samples from cutaneous lesions","volume":"53","author":"ML Cruz-Barrera","year":"2015"},{"key":"ref24","unstructured":"Gu\u00eda para la atenci\u00f3n cl\u00ednica integral del paciente con leishmaniasis. Organizaci\u00f3n Panamericana de la Salud OPS\/OMS. Convenio de Cooperaci\u00f3n T\u00e9cnica con el Ministerio de la Protecci\u00f3n Social Nro. 256 de 2009 y Nro. 237 de 2010. Bogot\u00e1 2010. Available at: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.ins.gov.co\" xlink:type=\"simple\">http:\/\/www.ins.gov.co<\/ext-link>. Accessed 21 September 2015."},{"issue":"4","key":"ref25","first-page":"1","article-title":"Interventions for American Cutaneous and Mucocutaneous Leishmaniasis: A Systematic Review Update","volume":"8","author":"L Reveiz","year":"2013"},{"issue":"4","key":"ref26","first-page":"421","article-title":"Short Report. Efficacy of Pentavalent. Antimony for treatment of Colombian Cutaneous Leishmaniasis","volume":"72","author":"J Soto","year":"2005"},{"issue":"2","key":"ref27","first-page":"340","article-title":"Outbreak of Cutaneous Leishmaniasis in Peruvian Military Personnel Undertaking Training Activities in the Amazon Basin, 2010","volume":"93","author":"M Or\u00e9","year":"2015"},{"issue":"6","key":"ref28","first-page":"824","article-title":"Cutaneous scars in American tegumentary leishmaniasis patients: a site of Leishmania (Viannia) braziliensis persistence and viability eleven years after antimonial therapy and clinical cure","volume":"58","author":"A Schubach","year":"1998"},{"issue":"sup.3","key":"ref29","first-page":"313","article-title":"Susceptibility of clinical strains of Leishmania to pentavalent antimony and Miltefosine: Challenges and oppotunities","volume":"31","author":"N Saravia","year":"2011"},{"key":"ref30","first-page":"11","article-title":"In vitro susceptibility to pentavalent antimony in Leishmania infantum strains is not modified during in vitro or in vivo passages but is modified after host tratment with meglumine antimoniate","volume":"2","author":"C Jaume","year":"2002"},{"issue":"1","key":"ref31","first-page":"139","article-title":"Leishmania panamensis infection and antimonial drugs modulate expression of macrophage drug transporters and metabolizing enzymes: impact on intracellular parasite survival","volume":"69","author":"MA G\u00f3mez","year":"2014"},{"issue":"12","key":"ref32","first-page":"1515","article-title":"Antimony in plasma and skin of patients with cutaneous leishmaniasis\u2014relationship with side effects after treatment with meglumine antimoniate","volume":"14","author":"DB Neves","year":"2009"},{"issue":"1","key":"ref33","first-page":"66","article-title":"Eficacia y tolerabilidad del Glucantime versus Estibogluconato s\u00f3dico en leishmaniosis de enero de 1999 a diciembre de 2001 en el C.S. San Camilo, Pozuzo\u2014Oxampampa","volume":"4","author":"O Belzusarri","year":"2004","journal-title":"Pasco."},{"issue":"6","key":"ref34","first-page":"513","article-title":"Evaluation of meglumine antimoniate effects on liver, kidney and p\u00e1ncreas function tests in patients with cutaneous leishmaniasis","volume":"17","author":"MN Kashani","year":"2007"},{"issue":"5","key":"ref35","first-page":"577","article-title":"Comparison of generic to branded Pentavalent Antimony for Treatment of New World Cutaneous Leishmaniasis","volume":"71","author":"J Soto","year":"2004"},{"issue":"2","key":"ref36","first-page":"201","article-title":"Role for CD4(+) CD25(+) regulatory T cells in reactivation of persistent leishmaniasis and control of concomitant immunity","volume":"200","author":"S Mendez","year":"2004"},{"issue":"2","key":"ref37","first-page":"226","article-title":"Activated inflammatory T cells correlate with lesion size in human cutaneous leishmaniasis","volume":"101","author":"L Antonelli","year":"2005"},{"issue":"2","key":"ref38","first-page":"e0148084","article-title":"The Role of Nitric Oxide and Reactive Oxygen Species in the Killing of Leishmania braziliensis by Monocytes from Patients with Cutaneous Leishmaniasis","volume":"11","author":"PP Carneiro","year":"2016"},{"issue":"2","key":"ref39","first-page":"65","article-title":"Immunoregulatory profile of monocytes from cutaneous leishmaniasis patients and association with lesion size","volume":"35","author":"\u00c9L Vieira","year":"2013"}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0004739","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T01:18:09Z","timestamp":1540257489000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0004739"}},"subtitle":[],"editor":[{"given":"David Joseph","family":"Diemert","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,5,31]]},"references-count":39,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2016,5,31]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0004739","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,31]]}}}